Elevated NLR has been linked to poor outcomes in HNSCC and other cancers [164, 165], while IFN-γ has been associated with favorable immunotherapy responses in several malignancies [166, 167]. This evidence concerns the gene IFNG and head and neck squamous cell carcinoma.